BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
3.950
-0.040 (-1.00%)
Sep 25, 2026, 4:00 PM EDT - Market closed
BridgeBio Oncology Therapeutics Employees
BridgeBio Oncology Therapeutics had 88 employees as of June 30, 2026. The number of employees increased by 26 or 41.94% compared to the same quarter last year.
Employees
88
Change
26
Growth
41.94%
Revenue / Employee
n/a
Profits / Employee
-$2,069,477
Market Cap
316.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 88 | 26 | 41.94% |
| Mar 31, 2026 | 106 | 44 | 70.97% |
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Sep 30, 2025 | 81 | 19 | 30.65% |
| Mar 31, 2025 | 62 | - | - |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| EyePoint | 214 |
| SAB Biotherapeutics | 86 |
| Century Therapeutics | 78 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| X4 Pharmaceuticals | 45 |
BBOT News
- 12 days ago - BridgeBio Oncology Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 16 days ago - JPMorgan cuts BridgeBio target, sees buying opportunity on selloff - TheFly
- 17 days ago - BridgeBio Oncology price target lowered to $27 from $39 at Leerink - TheFly
- 18 days ago - BridgeBio Oncology price target lowered to $22 from $24 at Raymond James - TheFly
- 18 days ago - BridgeBio Oncology price target lowered to $15 from $23 at Stifel - TheFly
- 18 days ago - BridgeBio Oncology price target lowered to $20 from $23 at Canaccord - TheFly
- 19 days ago - BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers - GlobeNewsWire
- 19 days ago - BridgeBio Oncology Therapeutics Slides: Corporate presentation - Filings